| |
| |
|
| Insider
Information: |
Fowler John Franklin |
| Relationship: |
CEO, Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
393,904 |
|
|
Indirect Shares
|
42,211 |
|
|
| Direct
Value |
$304,370 |
|
|
|
Indirect Value
|
$32,616 |
|
|
| Total
Shares |
436,115 |
|
|
| Total
Value |
$336,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 85.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kezar Life Sciences, Inc. |
KZR |
CEO, Director |
2022-11-10 |
393,904 |
2022-11-10 |
42,211 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2022-11-10 |
4 |
OE |
$0.90 |
$24,300 |
D/D |
27,000 |
393,904 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2021-12-14 |
4 |
OE |
$0.90 |
$6,930 |
D/D |
7,700 |
366,904 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2020-12-31 |
4 |
OE |
$0.90 |
$14,400 |
D/D |
16,000 |
359,204 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2020-02-04 |
4 |
B |
$2.60 |
$99,999 |
I/I |
38,461 |
38,461 |
2.66 |
% |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2019-12-19 |
4 |
OE |
$0.90 |
$45,000 |
D/D |
50,000 |
346,954 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2019-10-10 |
4 |
B |
$3.24 |
$3,235 |
I/I |
1,000 |
296,954 |
2.58 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2019-08-13 |
4 |
B |
$4.66 |
$9,310 |
I/I |
2,000 |
295,954 |
2.58 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2019-08-09 |
4 |
B |
$5.26 |
$2,628 |
D/D |
500 |
293,204 |
2.73 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CEO |
• • – |
2019-08-09 |
4 |
B |
$5.01 |
$3,761 |
I/I |
750 |
293,954 |
2.58 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
